Healthcare Specialty Enzymes Market Growth & Trends

The global healthcare specialty enzymes market size is estimated to reach USD 3.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2020 to 2027. Increasing penetration of enzymes in medical applications serves to be a key driving factor for the market. This is also supplemented by extensive research studies being carried out to explore the potential of enzymes in diagnosis as well as therapy. Diagnostic serum enzymes have gained significant attention for the quantification of these offers useful insights regarding abnormal tissue or an organ and help in predicting sites that are susceptible to tissue damage.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/healthcare-specialty-enzymes-market

Certain products such as aldolase, Creatine Phosphokinase (CPK), gamma-glutamyl transpeptidase, lactic dehydrogenase, lipase, and transaminases are routinely adopted for disease diagnosis. Aldolase is preferably used in the early-stage diagnosis of viral hepatitis as well as advanced prostate cancer. Whereas, CPK has caught the attention of healthcare professionals in terms of both diagnosis and research. CPK tests are performed to diagnose cardiac abnormalities, muscle-associated conditions along with differentiation of post-operative infection from malignant hyperthermia. Thus, the use of enzyme products expanding across various diagnostic applications is set to propel the demand for these products in the healthcare industry.

Enzyme dependent analytical procedures are carried out on a large scale; specificity and potency of these procedures enable amplification as well as detection of a specific target analyte. This has propelled the use of enzyme-based assays in the field of wet chemistry for the quantification of target substances and drugs. Soaring demand for immunodiagnostics, especially Enzyme-linked Immunosorbent Assay (ELISA) boosts the use of specialty enzymes in the amplification of the target signal. Whereas regular use of DNA polymerase for DNA amplification in DNA fingerprinting has increased considerably over the years.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com